BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
July 7, 2010
View Archived Issues
Study Reveals a Dozen New Diabetes Genes to Explore
Read More
Galapagos Enters $374M Osteoarthritis Pact with Servier
Read More
Swedish Orphan Biovitrum Eyes Manchurian Drug Candidates
Read More
Corrections & Clarifications
Read More
Postive Results Reported for NovaBiotics' Fungal Therapy
Read More
Other News To Note
Read More
Intercell's Adjuvant Patch Fails to Boost Pandemic Flu Vaccine
A faulty hemagglutinin inhibition assay may be the reason underlying the failure of a Phase II clinical trial of Intercell AG's investigational Vaccine Enhancement Patch (VEP) for H5N1 influenza. (BioWorld International)
Read More
Germany Funds Biobank Targeting Chronic Diseases
Read More